Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.
about
Evaluating the response of neoadjuvant chemotherapy for treatment of breast cancer: are tumor biomarkers and dynamic contrast enhanced MR images useful predictive tools?Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study.External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement.Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional studyPredictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer.The role of survivin in diagnosis, prognosis and treatment of breast cancer.Endometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary Tumors.Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical reviewDiagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile.ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosisPrognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma.Lateral differences in Ki-67 in breast cancerCorrelation between Ki67 and breast cancer prognosis.Ki67 and proliferation in breast cancer.Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study.Treatment response to preoperative anthracycline-based chemotherapy in locally advanced breast cancer: the relevance of proliferation and apoptosis rates.Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: a systematic review and meta-analysis.The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis.Modern therapies and iatrogenic changes in breast pathology.Different methods of pretreatment Ki-67 labeling index evaluation in core biopsies of breast cancer patients treated with neoadjuvant chemotherapy and their relation to response to therapy.Mitotic counts in breast cancer after neoadjuvant systemic chemotherapy and development of metastatic disease.Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer.Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer.Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy.Evaluation of ER, PgR, HER-2, Ki-67, cyclin D1, and nm23-H1 as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer.
P2860
Q33814616-C9CBAAFC-2A8E-4E5B-BA92-2DB33C581EEFQ33896397-358A8652-5C7A-42B5-A515-A8BBB1537BDEQ34075697-1D01D60D-A38F-4E31-B6BA-D39E06D10963Q34567461-98A9D34A-4B58-4D99-99EC-0F99A4C034BCQ35237197-AE080C8B-F5B4-4202-AE5C-A3834490E712Q35667653-E514885B-2219-410D-BD35-124DFDAD810EQ35739831-FAD21BD4-D248-4819-9977-0314E6C3C20AQ35904441-7624E932-396C-4215-8A66-44619F8C34DDQ35928203-3ED88361-96A1-4479-8483-52B784AD58C6Q36175526-778F5269-39B9-446F-84C9-954262115EB5Q36295045-28FF8CAD-2BDC-49B7-8D73-85FB6C590989Q36953869-94F1E7C0-44D1-4CD1-8B1B-BABC4ED5E0C3Q38077896-7E8A5E82-C3FC-4631-9061-1A8C882A2FDBQ38084286-38E57F2E-B2DA-4801-A6E2-FC2AA00AFAE3Q38395457-DFA3EA40-A2DB-4C30-A62E-8A2EF264B0F1Q38397572-83CCA766-38F0-4571-A1FB-ABD39AE6AE0CQ38770344-817FF912-7B42-4E45-9A00-D7A2E6D17C81Q38771946-5F744C30-ED1C-474E-9DEB-B0D924BF4D89Q39037636-1523DF25-1E3B-45B8-8909-2C62EFCC0324Q40195184-B61D407F-AE26-465B-BC0F-8203C55B670FQ43780773-1455B681-FBDB-45C6-8FFB-7750E77DCD5DQ44966169-7114608D-F6AB-4D12-9E15-CFE2A63B42E9Q47362424-37FC4022-C7B3-4F42-8E7F-1396601B0B8FQ54609676-01A54EA4-DBEF-4536-92AF-7B1B9FCEDDD0Q54649694-1F98EFB6-7921-4B5A-AE60-DE19E28B74C7
P2860
Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Changes and predictive and pro ...... with neoadjuvant chemotherapy.
@en
Changes and predictive and pro ...... with neoadjuvant chemotherapy.
@nl
type
label
Changes and predictive and pro ...... with neoadjuvant chemotherapy.
@en
Changes and predictive and pro ...... with neoadjuvant chemotherapy.
@nl
prefLabel
Changes and predictive and pro ...... with neoadjuvant chemotherapy.
@en
Changes and predictive and pro ...... with neoadjuvant chemotherapy.
@nl
P2093
P50
P1433
P1476
Changes and predictive and pro ...... with neoadjuvant chemotherapy
@en
P2093
Florence Mishellany
Frédérique Penault-Llorca
Inès Raoelfils
Marie-Ange Mouret-Reynier
Philippe Chollet
Pierre Gimbergues
P304
P356
10.1634/THEONCOLOGIST.2008-0073
P577
2008-12-17T00:00:00Z